Profil
Steve Damment is the founder of Aluztura Bio Ltd. which is founded in 2014, where he holds the title of Chief Science Officer.
He held the position of Senior Vice President-Biosciences at Shire Plc from 2000 to 2013 and at GSK Plc from 1982 to 1999.
He also held the position of Executive Vice President-Research & Development at Biodexa Pharmaceuticals Plc from 2018 to 2021.
Dr. Damment received his undergraduate degree from The University of Liverpool.
Aktive Positionen von Steve Damment
| Unternehmen | Position | Beginn |
|---|---|---|
Aluztura Bio Ltd. | Gründer | 01.01.2014 |
Ehemalige bekannte Positionen von Steve Damment
| Unternehmen | Position | Ende |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Technik-/Wissenschafts-/F&E-Leiter | 30.09.2021 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Corporate Officer/Principal | 01.12.2013 |
| GSK PLC | Corporate Officer/Principal | 01.12.1999 |
Ausbildung von Steve Damment
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines | Health Technology |
Aluztura Bio Ltd. |
















